Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Yang, Jaemoon | - |
dc.contributor.author | Lim, Eun-Kyung | - |
dc.contributor.author | Lee, Hong Jae | - |
dc.contributor.author | Park, Joseph | - |
dc.contributor.author | Lee, Sang Cheon | - |
dc.contributor.author | Lee, Kwangyeol | - |
dc.contributor.author | Yoon, Ho-Geun | - |
dc.contributor.author | Suh, Jin-Suck | - |
dc.contributor.author | Huh, Yong-Min | - |
dc.contributor.author | Haam, Seungjoo | - |
dc.date.accessioned | 2021-09-09T08:02:43Z | - |
dc.date.available | 2021-09-09T08:02:43Z | - |
dc.date.created | 2021-06-10 | - |
dc.date.issued | 2008-06 | - |
dc.identifier.issn | 0142-9612 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/123510 | - |
dc.description.abstract | Cetuximab conjugated fluorescent magnetic nanohybrids (CET-FMNHs) were synthesized for detection of human epithelial cancer via magnetic resonance (MR) and optical imaging. Spherical FMNHs consist of MnFe2O4 magnetic nanocrystals encapsulated in pyrene-labeled PCL-b-PMAA as a surfactant prepared by a nano-emulsion method. FMNHs demonstrated excellent colloidal stability and biocompatibility for biomedical application. Antibody conjugated fluorescent magnetic nanohybrids (CET-FMNHs) served as effective agents for both magnetic resonance (MR) and fluorescence optical imaging of cancer cell lines. (c) 2008 Elsevier Ltd. All rights reserved. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | ELSEVIER SCI LTD | - |
dc.subject | SUPERPARAMAGNETIC NANOPARTICLES | - |
dc.subject | QUANTUM DOTS | - |
dc.subject | NANOCRYSTALS | - |
dc.subject | DIAGNOSIS | - |
dc.subject | ANTIBODY | - |
dc.title | Fluorescent magnetic nanohybrids as multimodal imaging agents for human epithelial cancer detection | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwangyeol | - |
dc.identifier.doi | 10.1016/j.biomaterials.2007.12.036 | - |
dc.identifier.scopusid | 2-s2.0-40949116615 | - |
dc.identifier.wosid | 000255428100012 | - |
dc.identifier.bibliographicCitation | BIOMATERIALS, v.29, no.16, pp.2548 - 2555 | - |
dc.relation.isPartOf | BIOMATERIALS | - |
dc.citation.title | BIOMATERIALS | - |
dc.citation.volume | 29 | - |
dc.citation.number | 16 | - |
dc.citation.startPage | 2548 | - |
dc.citation.endPage | 2555 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalResearchArea | Materials Science | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.relation.journalWebOfScienceCategory | Materials Science, Biomaterials | - |
dc.subject.keywordPlus | SUPERPARAMAGNETIC NANOPARTICLES | - |
dc.subject.keywordPlus | QUANTUM DOTS | - |
dc.subject.keywordPlus | NANOCRYSTALS | - |
dc.subject.keywordPlus | DIAGNOSIS | - |
dc.subject.keywordPlus | ANTIBODY | - |
dc.subject.keywordAuthor | magnetic nanoparticle | - |
dc.subject.keywordAuthor | fluorescence | - |
dc.subject.keywordAuthor | nanohybrid | - |
dc.subject.keywordAuthor | cancer | - |
dc.subject.keywordAuthor | cetuximab | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.